Dextera Surgical (DXTR) Tops Q2 EPS by 30c

Dextera Surgical (NASDAQ: DXTR) reported Q2 EPS of ($0.04), $0.30 better than the analyst estimate of ($0.34). Revenue for the quarter came in at $800 thousand versus the consensus estimate of $670 thousand.

For earnings history and earnings-related data on Dextera Surgical (DXTR) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15